site stats

Tga nimenrix product information

WebNIMENRIX against the possible risks. If you have any questions about NIMENRIX, ask your doctor, nurse or pharmacist. Keep this leaflet. You may need to read it again. What NIMENRIX is used for NIMENRIX is a vaccine used to help prevent meningococcal disease, caused by four types of Neisseria meningitidis bacteria (types A, C, W and Y). WebNIMENRIX is indicated for active immunisation of individuals from 6 weeks of age against invasive meningococcal diseases caused by . Neisseria meningitidis. groups A, C, W-135 …

Nimenrix - Immunisation Advisory Centre

WebNimenrix is a meningococcal conjugate vaccine to protect against meningococcal groups A, C, W and Y. In New Zealand, Nimenrix is only available as a purchased vaccine for … Web30 May 2024 · Nimenrix Active Ingredient: meningococcal groups A, C, W-135 and Y conjugate vaccine Company: Pfizer Limited See contact details About Medicine … rope access solutions gmbh https://ardingassociates.com

ΠΑΡΑΡΤΗΜΑ I ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ …

Web6. Contents of the pack and other information 1. What Nimenrix is and what it is used for What Nimenrix is and what it is used for Nimenrix is a vaccine which helps protect … WebPharmacodynamic properties for further information). Long-term antibody persistence data following vaccination with NIMENRIX are available up to 10 years after vaccination (see Sections 4.4 Special Warnings and Precautions for Use and 5.1 Pharmacodynamic Properties). NIMENRIX may be given as a booster dose to individuals who have previously … WebNIMENRIX PRODUCT INFORMATION NAME OF THE MEDICINE Meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine DESCRIPTION NIMENRIX … rope access uk

Safety Data Sheets Pfizer

Category:Safety Data Sheets Pfizer

Tags:Tga nimenrix product information

Tga nimenrix product information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European …

WebFor Product Information and Consumer Medicine Information about Priorix-tetra visit the Therapeutic Goods Administration website. Additional vaccine information. For detailed … WebNIMENRIX (meningococcal Group A, C, W135 and Y conjugate vaccine) 4 Clinical Particulars Pfizer Medical Information - UK NIMENRIX (meningococcal Group A, C, W135 and Y conjugate vaccine) 4 Clinical Particulars This site is intended for UK healthcare professionals and the information provided is not intended as medical advice.

Tga nimenrix product information

Did you know?

Web17 Sep 2024 · Product information Assessment history Authorised This medicine is authorised for use in the European Union. Overview Nimenrix is a vaccine used to protect … Web16 Feb 2024 · It provides objective information about the quality, safety and effectiveness of the medicine, as demonstrated in the data provided to the TGA by the pharmaceutical …

WebNIMENRIX medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the prescibing information, announcements, resources, …

WebWhat Nimenrix is and what it is used for. Nimenrix is a vaccine which helps protect against infections caused by bacteria (germs) called “Neisseria meningitidis" types A, C, W-135 … WebNIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe (199742) Therapeutic Goods Administration …

WebNimenrix (developed by GlaxoSmithKline and later acquired by Pfizer), is a quadrivalent conjugate vaccine against serogroups A, C, W-135, and Y. In April 2012 Nimenrix was …

WebIntramuscular injection Subcutaneous injection Vaccine group Monovalent vaccines Description: Registered for use in infants and children aged 2 months to 5 years. … rope and a yardstick songWebPharmacodynamic properties for further information). Long-term antibody persistence data following vaccination with NIMENRIX are available up to 10 years after vaccination (see … rope and dallyWeb1 Oct 2015 · This release contains forward-looking information about the acquisition by Pfizer of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines, Nimenrix and Mencevax, and the potential benefits thereof, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or … rope access technician sydneyWebToggle menu ... Search rope and balls the gameWeb5 Apr 2024 · The Australian Technical Advisory Group on Immunisation (ATAGI) has developed advice on the introduction of meningococcal ACWY vaccine (Nimenrix®) for adolescents through the National Immunisation Program (NIP). It includes information about: recommendations for the use of meningococcal ACWY vaccine rope and boysWeb5 May 2024 · You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or … rope access window cleaning londonWebΤο Nimenrix θα πρέπει να χορηγείται προσεκτικά σε άτομα με θρομβοπενία ή οποιαδήποτε διαταραχή πηκτικότητας, καθώς μπορεί να επακολουθήσει αιμορραγία μετά από ενδομυϊκή … rope and anchor svg